Sana Biotechnology (SANA) Interest & Investment Income (2020 - 2026)

Sana Biotechnology recorded quarterly Interest & Investment Income of $951000.0 in Q1 2026, down 25.47% quarter-over-quarter from $1.3 million in Q4 2025, and down 4.13% year-over-year from $992000.0 in Q1 2025.

Sana Biotechnology's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $951000.0 for Q1 2026.

  • In Q1 2026, Interest & Investment Income fell 4.13% year-over-year to $951000.0; the TTM figure through Mar 2026 stood at $3.8 million (down 54.83% YoY), while the FY2025 annual figure was $3.8 million, down 63.25% from the prior year.
  • Interest & Investment Income came in at $951000.0 for Q1 2026 at Sana Biotechnology, down from $1.3 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $3.2 million in Q2 2024 to a low of $339000.0 in Q1 2022.
  • A 5-year average of $1.7 million and a median of $1.6 million in 2022 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income surged 642.41% in 2022 and sank 81.98% in 2025, its largest moves.
  • Sana Biotechnology's Interest & Investment Income stood at $1.6 million in 2022, then surged by 69.0% to $2.7 million in 2023, then plunged by 39.25% to $1.7 million in 2024, then dropped by 22.95% to $1.3 million in 2025, then slipped by 25.47% to $951000.0 in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $951000.0, $1.3 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 7.90 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 114.80 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 305,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 26.60 Mn
10 Sana Biotechnology 890.09 Mn 890.09 Mn - 951,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 951,000.00
Dec 31, 2025 1.28 Mn
Sep 30, 2025 1.00 Mn
Jun 30, 2025 577,000.00
Mar 31, 2025 992,000.00
Dec 31, 2024 1.66 Mn
Sep 30, 2024 2.58 Mn
Jun 30, 2024 3.20 Mn
Mar 31, 2024 3.03 Mn
Dec 31, 2023 2.73 Mn
Sep 30, 2023 2.86 Mn
Jun 30, 2023 2.37 Mn
Mar 31, 2023 1.98 Mn
Dec 31, 2022 1.61 Mn
Sep 30, 2022 1.17 Mn
Jun 30, 2022 637,000.00
Mar 31, 2022 339,000.00
Dec 31, 2021 267,000.00
Sep 30, 2021 158,000.00
Jun 30, 2021 130,000.00
Mar 31, 2021 121,000.00
Dec 31, 2020 125,000.00
Sep 30, 2020 148,000.00
Jun 30, 2020 79,000.00
Mar 31, 2020 395,000.00